STML - Stemline Therapeutics, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
-0.10 (-0.58%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous close17.30
Bid0.00 x 0
Ask0.00 x 0
Day's range17.00 - 17.60
52-week range7.30 - 18.75
Avg. volume361,822
Market cap478.913M
PE ratio (TTM)N/A
EPS (TTM)-2.94
Earnings date8 May 2018 - 14 May 2018
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est32.67
Trade prices are not sourced from all markets
  • Associated Presslast month

    Stemline Therapeutics reports 4Q loss

    On a per-share basis, the New York-based company said it had a loss of 93 cents. For the year, the company reported that its loss widened to $67.8 million, or $2.94 per share. Revenue was reported as $898,000. ...

  • Globe Newswire3 months ago

    Stemline Therapeutics Closes $59.6 Million Public Offering of Common Stock

    NEW YORK, Jan. 26, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, today announced the closing of a previously announced underwritten public offering of 4,255,000 shares of its common stock, which included the exercise in full of the option to purchase 555,000 additional shares, at a price of $14.00 per share. ...

  • Business Wire3 months ago

    Newman Ferrara LLP Announces Corporate Governance Investigation of Stemline Therapeutics Inc. - STML

    Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of Stemline Therapeutics Inc. into potential breaches of fiduciary duty by the Company’s Board of Directors .

  • Associated Press5 months ago

    Stemline Therapeutics reports 3Q loss

    The New York-based company said it had a loss of 68 cents per share. The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a ...

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes